「Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer」の関連論文
-
Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers
-
Development of a novel cancer therapy with a ferroptosis inducer and radiation, and a prediction method for therapeutic effects targeting ferroptosis
-
Targeting tumor-intrinsic Nuclear Factor-kappa B signaling pathway for the discovery of anti-metastatic drug candidates from natural recourses
-
The loss of endothelin-2 exhibits an anticancer effect in A549 human lung adenocarcinoma cell line
-
Influence of human adipose stem cells on prostate cancer cell growth
-
Interleukin (IL)-17A is a potent prognostic factor associated with intratumoral neutrophil infiltration and C-X-C chemokine motif ligand 1 in triple-negative breast cancer
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
KRAS Inhibitor Resistance in MET-Amplified KRAS G12C Non–Small Cell Lung Cancer Induced By RAS- and Non–RAS-Mediated Cell Signaling Mechanisms
-
PCBP2 knockdown promotes ferroptosis in malignant mesothelioma
-
Inactivation of the PD-1-dependent immunoregulation in mice exacerbates contact hypersensitivity resembling immune-related adverse events
-
PBK expression predicts favorable survival in colorectal cancer patients
-
Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
The epithelial-mesenchymal transition phenotype is associated with the frequency of tumor spread through air spaces (STAS) and a High risk of recurrence after resection of lung carcinoma
-
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
-
Elicitation of Inhibitory Effects for AGE-Induced Oxidative Stress in Rotator Cuff-Derived Cells by Apocynin
-
Nectin-4 regulates cellular senescence-associated enlargement of cell size
-
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
-
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Myogenetic Oligodeoxynucleotide Restores Differentiation and Reverses Inflammation of Myoblasts Aggravated by Cancer-Conditioned Medium
-
Important Role of Concomitant Lymphangiogenesis for Reparative Angiogenesis in Hindlimb Ischemia
-
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
-
Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma (本文)
-
Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression
-
CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
-
Photodynamic Therapy for Cancer using Mitochondrial Drug Delivery System
-
卵巣低異型度漿液性癌のin vitro発癌モデル
-
Oncolytic HSV-1 in combination with lenalidomide for plasma cell neoplasms
-
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
-
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
-
Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart
-
Nucleolar stress: Molecular mechanisms and related human diseases
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
l-Asparaginase regulates mTORC1 activity via a TSC2-dependent pathway in pancreatic beta cells
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement
-
An Integrated In Silico and In Vivo Approach to Identify Protective Effects of Palonosetron in Cisplatin-Induced Nephrotoxicity
-
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
-
Dissecting the Intracellular Molecular Mechanisms to Address Pathogenesis of Multifactorial Diseases
-
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells
-
Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL- induced caspase activation
-
Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL- induced caspase activation
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APC (min/+) mouse model
-
Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway